(Q35938575)

11 August 2017

Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS (English)

1 reference

11 August 2017

1 reference

1 reference

ChEBI release 2020-05-28

S Gheuens

1

1 reference

11 August 2017

D R Smith

2

1 reference

11 August 2017

X Wang

3

1 reference

11 August 2017

D C Alsop

4

1 reference

11 August 2017

R E Lenkinski

5

1 reference

11 August 2017

I J Koralnik

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

18 April 2012

1 reference

11 August 2017

1 reference

11 August 2017

78

1 reference

11 August 2017

18

1 reference

11 August 2017

1390-1393

1 reference

Neurological complications of immune reconstitution in HIV-infected populations

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345789

Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345789

Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345789

Proton MR Spectroscopy of Progressive Multifocal Leukoencephalopathy−Immune Reconstitution Inflammatory Syndrome: Fig 1

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345789

Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3345789

Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22517104

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22517104

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22517104

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0B013E318253D61E

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22517104

1 reference